Salkind Gene bought UPXI
July 3, 2026 · Form 4 insider transaction
Salkind Gene bought 100,000 shares of Upexi, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderSalkind Gene
RoleDirector
CompanyUpexi, Inc. (UPXI)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 3, 2026
Filing dateJuly 20, 2026
Shares owned after318,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock granted pursuant to the Issuer's 2019 Incentive Stock Plan, as amended, that vests in four equal quarterly installments, with full vesting on July 1, 2027, subject to continued service.